On Monday, Appian Cl A received a positive adjustment to its Relative Strength (RS) Rating, from 68 to 72.
IBD's proprietary RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains often have an RS Rating north of 80 as they launch their biggest price moves. See if Appian Cl A can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Appian Cl A is still inside a buy range after climbing above a 35.99 entry in a cup with handle. The proper buying range extends to 5% above the initial entry. Once a stock hits that benchmark, it's best to hold off investing and wait for it to set up another buying opportunity..
The company reported 0% earnings growth in the latest quarterly report. Revenue increased 15%. The next quarterly results are expected on or around Nov. 7.
Appian Cl A holds the No. 9 rank among its peers in the Computer Software-Design industry group. Autodesk, Altair Engineering Cl A and Cadence Design Systems are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
